Number of the records: 1  

Combatting Nitrosative Stress and Inflammation with Novel Substituted Triazinoindole Inhibitors of Aldose Reductase in PC12 Cells Exposed to 6-Hydroxydopamine Plus High Glucose

  1. TitleCombatting Nitrosative Stress and Inflammation with Novel Substituted Triazinoindole Inhibitors of Aldose Reductase in PC12 Cells Exposed to 6-Hydroxydopamine Plus High Glucose
    Author Elmazoglu Zübeyir
    Co-authors Šoltésová Prnová Marta 1986- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV    SCOPUS    ORCID

    Santamaria Abel

    Štefek Milan 1950-2023 SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV    SCOPUS    ORCID

    Karasu Çimen

    Source document Neurotoxicity Research. Vol. 39, no. 2 (2021), p. 210-226
    Languageeng - English
    CountryUS - United States of America
    NoteTUBITAK Project No: 215S197
    Document kindrozpis článkov z periodík (rbx)
    CitationsBALESTRI, Francesco - POLI, Giulio - PIAZZA, Lucia - CAPPIELLO, Mario - MOSCHINI, Roberta - SIGNORE, Giovanni - TUCCINARDI, Tiziano - MURA, Umberto - DEL CORSO, Antonella. Dissecting the Activity of Catechins as Incomplete Aldose Reductase Differential Inhibitors through Kinetic and Computational Approaches. In BIOLOGY-BASEL, 2022, vol. 11, no. 9, pp. Dostupné na: https://doi.org/10.3390/biology11091324.
    BAILLY, Christian. Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer. In EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, vol. 931, no., pp. ISSN 0014-2999. Dostupné na: https://doi.org/10.1016/j.ejphar.2022.175191.
    TASSOPOULOU, Vassiliki-Panagiota - TZARA, Ariadni - KOUROUNAKIS, Angeliki P. Design of Improved Antidiabetic Drugs: A Journey from Single to Multitarget Agents. In CHEMMEDCHEM, 2022, vol. 17, no. 23, pp. ISSN 1860-7179. Dostupné na: https://doi.org/10.1002/cmdc.202200320.
    BAVI, Ensieh Poshtkouhian - SHAKERINASAB, Ehsan - HAMIDINEZHAD, Habib - NAZIFI, Ehsan. A green and facile approach for fabrication of biocompatible anti-Parkinson chitosan-gelatin-green tea extract composite particles with neuroprotective and Neurotherapeutic effects: In vitro evaluation. In INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, vol. 224, no., pp. 1183-1195. ISSN 0141-8130. Dostupné na: https://doi.org/10.1016/j.ijbiomac.2022.10.204.
    ZMYSLOWSKA-POLAKOWSKA, E. - PLOSZAJ, T. - SKOCZYLAS, S. - MOJSAK, P. - CIBOROWSKI, M. - KRETOWSKI, A. - LUKOMSKA-SZYMANSKA, M. - SZADKOWSKA, A. - MLYNARSKI, W. - ZMYSLOWSKA, A. Evaluation of the Oral Bacterial Genome and Metabolites in Patients with Wolfram Syndrome. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, vol. 24, no. 6, pp. Dostupné na: https://doi.org/10.3390/ijms24065596.
    SEQUEIRA, L. - BENFEITO, S. - FERNANDES, C. - LIMA, I. - PEIXOTO, J. - ALVES, C. - MACHADO, C.S. - GASPAR, A. - BORGES, F. - CHAVARRIA, D. Drug Development for Alzheimer's and Parkinson's Disease: Where Do We Go Now?. In PHARMACEUTICS. JUN 2024, vol. 16, no. 6. Dostupné na: https://doi.org/10.3390/pharmaceutics16060708.
    CategoryADMA - Scientific papers in foreign impacted journals registered in Web of Sciences or Scopus
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2021
    Registered inWOS
    Registered inSCOPUS
    DOI 10.1007/s12640-020-00305-x
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    N
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    202120203.911Q20.923Q2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.